Back
Apollo Global Management Vs. Akero Therapeutics Industry Stock Comparison
Buy
66
APO
Apollo Global Management
Last Price:
110.61
Seasonality Move:
9.35%
Sell
30
AKRO
Akero Therapeutics
Last Price:
20.78
Seasonality Move:
16.32%
Buy
66
Apollo Global Management (APO)
is a Buy
Is Apollo Global Management a Buy, Sell or Hold?
- The current Apollo Global Management [APO] share price is $107.63. The Score for APO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- APO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $20.74. The Score for AKRO is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APO Stock Price Chart
What is Apollo Global Management's stock price today?
-
The Apollo Global Management share price today is $107.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $20.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
APO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 41.85 | Sell |
| Chaikin Money Flow: | 165011 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (109.09 - 114.03) | Sell |
| Bollinger Bands (100): | (94.67 - 111.65) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.18 | Sell |
| Relative Strength Index (14 RSI): | 32.95 | Sell |
| Chaikin Money Flow: | 36590 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.81 - 25.45) | Sell |
| Bollinger Bands (100): | (19.7 - 26.14) | Sell |
APO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.4 | Sell |
| 20-day SMA: | 111.52 | Sell |
| 50-day SMA: | 111.01 | Sell |
| 200-day SMA: | 94.03 | Buy |
| 8-day EMA: | 108.97 | Sell |
| 20-day EMA: | 110.39 | Sell |
| 50-day EMA: | 108.92 | Sell |
| 200-day EMA: | 95.23 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.55 | Sell |
| 20-day SMA: | 22.97 | Sell |
| 50-day SMA: | 24.61 | Sell |
| 200-day SMA: | 29.44 | Sell |
| 8-day EMA: | 21.6 | Sell |
| 20-day EMA: | 22.88 | Sell |
| 50-day EMA: | 23.74 | Sell |
| 200-day EMA: | 27.82 | Sell |
Apollo Global Management Earnings Growth & APO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.15 per share, an increase this year of $1.12 per share, and an increase next year of $1.31 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.
Apollo Global Management Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||